Your browser doesn't support javascript.
loading
Luseogliflozin, a sodium-glucose cotransporter-2 inhibitor, reverses cerebrovascular dysfunction and cognitive impairments in 18-mo-old diabetic animals.
Wang, Shaoxun; Jiao, Feng; Border, Jane J; Fang, Xing; Crumpler, Reece F; Liu, Yedan; Zhang, Huawei; Jefferson, Joshua; Guo, Ya; Elliott, Parker S; Thomas, Kirby N; Strong, Luke B; Urvina, Austin H; Zheng, Baoying; Rijal, Arjun; Smith, Stanley V; Yu, Hongwei; Roman, Richard J; Fan, Fan.
Affiliation
  • Wang S; Department of Pharmacology and Toxicology, University of Mississippi Medical Center, Jackson, Mississippi.
  • Jiao F; Department of Pharmacology and Toxicology, University of Mississippi Medical Center, Jackson, Mississippi.
  • Border JJ; Department of Pharmacology and Toxicology, University of Mississippi Medical Center, Jackson, Mississippi.
  • Fang X; Department of Pharmacology and Toxicology, University of Mississippi Medical Center, Jackson, Mississippi.
  • Crumpler RF; Department of Pharmacology and Toxicology, University of Mississippi Medical Center, Jackson, Mississippi.
  • Liu Y; Department of Pharmacology and Toxicology, University of Mississippi Medical Center, Jackson, Mississippi.
  • Zhang H; Department of Pharmacology and Toxicology, University of Mississippi Medical Center, Jackson, Mississippi.
  • Jefferson J; Department of Pharmacology and Toxicology, University of Mississippi Medical Center, Jackson, Mississippi.
  • Guo Y; Department of Pharmacology and Toxicology, University of Mississippi Medical Center, Jackson, Mississippi.
  • Elliott PS; Department of Pharmacology and Toxicology, University of Mississippi Medical Center, Jackson, Mississippi.
  • Thomas KN; Department of Pharmacology and Toxicology, University of Mississippi Medical Center, Jackson, Mississippi.
  • Strong LB; Department of Pharmacology and Toxicology, University of Mississippi Medical Center, Jackson, Mississippi.
  • Urvina AH; Department of Pharmacology and Toxicology, University of Mississippi Medical Center, Jackson, Mississippi.
  • Zheng B; Department of Pharmacology and Toxicology, University of Mississippi Medical Center, Jackson, Mississippi.
  • Rijal A; Department of Pharmacology and Toxicology, University of Mississippi Medical Center, Jackson, Mississippi.
  • Smith SV; Department of Pharmacology and Toxicology, University of Mississippi Medical Center, Jackson, Mississippi.
  • Yu H; Department of Anesthesiology, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Roman RJ; Department of Pharmacology and Toxicology, University of Mississippi Medical Center, Jackson, Mississippi.
  • Fan F; Department of Pharmacology and Toxicology, University of Mississippi Medical Center, Jackson, Mississippi.
Am J Physiol Heart Circ Physiol ; 322(2): H246-H259, 2022 02 01.
Article in En | MEDLINE | ID: mdl-34951541
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sorbitol / Dementia, Vascular / Diabetic Angiopathies / Sodium-Glucose Transporter 2 Inhibitors Type of study: Risk_factors_studies Limits: Animals Language: En Journal: Am J Physiol Heart Circ Physiol Journal subject: CARDIOLOGIA / FISIOLOGIA Year: 2022 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sorbitol / Dementia, Vascular / Diabetic Angiopathies / Sodium-Glucose Transporter 2 Inhibitors Type of study: Risk_factors_studies Limits: Animals Language: En Journal: Am J Physiol Heart Circ Physiol Journal subject: CARDIOLOGIA / FISIOLOGIA Year: 2022 Document type: Article Country of publication: